Divi's Labs

Divi’s Laboratories Analysis

I. Overview

Established in the year 1990, Divi Research Center focused on research and development in the Pharmaceutical Preparations industry. With this fundamental, the company experienced substantial growth by developing new processes for the production of Active Pharmaceutical Ingredients (or APIs) in intermediaries. In 5 years they established Divi’s first manufacturing facility after changing their name to Divi’s Laboratories in 1994. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.Headquartered in Hyderabad, India, Divi’s Laboratories is a multinational company and operates in many countries around the world. Listed under SIC codes as Pharmaceutical Preparations, and its stock exchanged in the Bombay Stock Exchange; Divi’s Laboratories has positioned itself to be an up and coming competitor in the industry. The value of output of APIs in India during 2007 was US $4.1 Billion and India ranked fourth in the world in terms of API output. With many European and American Pharmaceutical companies outsourcing their API production, this factor continues to strengthen and prosper the industry. Divi’s Laboratories stated their mission as, “to maintain leadership in custom synthesis of APIs and Intermediates for health care and life sciences industry and to be one of the top companies world-wide in the domain. To develop generic APIs for the late life cycle needs of the Industry.” This has a clear focus of research and development with a clear understanding of their position in the industry. By focusing on generics, Divi’s is able to capture and utilize it’s expertise to gain market share. II. Business Nature Identification

Products

{text:list-item}

Any component that is intended to furnish...